Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Other Non-Current Liabilities (2016 - 2025)

Conmed's Other Non-Current Liabilities history spans 16 years, with the latest figure at $63.9 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 26.01% year-over-year to $63.9 million; the TTM value through Dec 2025 reached $63.9 million, down 26.01%, while the annual FY2025 figure was $63.9 million, 26.01% down from the prior year.
  • Other Non-Current Liabilities reached $63.9 million in Q4 2025 per CNMD's latest filing, down from $71.7 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $218.1 million in Q3 2022 to a low of $41.8 million in Q1 2022.
  • Average Other Non-Current Liabilities over 5 years is $103.6 million, with a median of $90.5 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: soared 373.8% in 2022, then plummeted 41.41% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $43.0 million in 2021, then skyrocketed by 373.8% to $203.7 million in 2022, then crashed by 40.58% to $121.0 million in 2023, then dropped by 28.7% to $86.3 million in 2024, then decreased by 26.01% to $63.9 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Other Non-Current Liabilities are $63.9 million (Q4 2025), $71.7 million (Q3 2025), and $79.8 million (Q2 2025).